Systemic Capillary Leak Syndrome as an Initial Presentation of ALK-Negative Anaplastic Large Cell Lymphoma

被引:10
|
作者
Lourdes, Laura S. [1 ]
Al-Quran, Samer Z. [2 ]
Dang, Nam H. [3 ]
Markham, Merry-Jennifer [3 ]
机构
[1] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Med, Div Hematol & Oncol, POB 100278, Gainesville, FL 32610 USA
关键词
D O I
10.1155/2012/954201
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic capillary leak syndrome (SCLS) is a rare disease characterized by third spacing of plasma into the extravascular compartment, leading to anasarca, hemoconcentration, and hypovolemic shock. It has been rarely associated with lymphomas, and reports usually indicate that it occurs after antineoplastic treatment. We present the case of a patient with ALK-negative anaplastic large cell lymphoma who presented with SCLS as the initial manifestation of her lymphoma. The SCLS resolved with treatment of the malignancy with steroids and chemotherapy.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Systemic ALK-negative anaplastic large cell lymphoma with distinctive myxoid change and DUSP22 rearrangement
    Stefano Fratoni
    Malgorzata Monika Trawinska
    Anna Capalbo
    Laura Bernardini
    Maria Fabbretti
    Maurizio Martini
    Pasquale Niscola
    Xiangfeng Frank Zhao
    Virchows Archiv, 2022, 481 : 975 - 979
  • [32] ALK-negative anaplastic large cell lymphoma masquerading as allergic contact dermatitis of the face
    Thomas, L.
    Cousen, P.
    Svec, A.
    Robinson, K.
    Carmichael, A. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (04) : E122 - E122
  • [33] Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
    G Hu
    S Dasari
    Y W Asmann
    P T Greipp
    R A Knudson
    H K Benson
    Y Li
    B W Eckloff
    J Jen
    B K Link
    L Jiang
    J S Sidhu
    L E Wellik
    T E Witzig
    N N Bennani
    J R Cerhan
    R L Boddicker
    A L Feldman
    Leukemia, 2018, 32 : 565 - 569
  • [34] ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature
    Lannon, Melissa
    Lu, Jian-Qiang
    Chum, Marvin
    Wang, Bill Hao
    BRITISH JOURNAL OF NEUROSURGERY, 2023, 37 (05) : 1245 - 1250
  • [35] ALK-negative anaplastic large cell lymphoma in leukemic phase with near-pentaploidy
    Wong, W. S.
    Liu, Brenda W. F.
    Lam, Frankie S. C.
    Wong, K. F.
    LEUKEMIA & LYMPHOMA, 2010, 51 (10) : 1927 - 1930
  • [36] Occult ALK-negative anaplastic large cell lymphoma complicating chronic lymphocytic leukemia
    Ahmed, Reham
    Feldman, Andrew L.
    BLOOD, 2024, 143 (10) : 938 - 938
  • [37] Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
    Hu, G.
    Dasari, S.
    Asmann, Y. W.
    Greipp, P. T.
    Knudson, R. A.
    Benson, H. K.
    Li, Y.
    Eckloff, B. W.
    Jen, J.
    Link, B. K.
    Jiang, L.
    Sidhu, J. S.
    Wellik, L. E.
    Witzig, T. E.
    Bennani, N. N.
    Cerhan, J. R.
    Boddicker, R. L.
    Feldman, A. L.
    LEUKEMIA, 2018, 32 (02) : 565 - 569
  • [38] BRENTUXIMAB VEDOTIN FOR T-CELL LYMPHOMA: A CASE OF ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
    Sumbly, V.
    Landry, I.
    Rizzo, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (04) : 1155 - 1155
  • [39] ALK-Negative Anaplastic Large Cell Lymphoma Presenting as Disseminated Intravascular Coagulation and Hemophagocytic Lymphohistiocytosis: A Potentially Fatal Presentation
    Ibrahim, Uroosa
    Saqib, Amina
    Rehan, Maryam
    Atallah, Jean Paul
    CASE REPORTS IN HEMATOLOGY, 2018, 2018
  • [40] The expressions of MUM-1 and Bcl-6 in ALK-negative systemic anaplastic large cell lymphoma with skin involvement and primary cutaneous anaplastic large cell lymphoma
    Cho, Yeo-Rye
    Seo, Jeong-Wan
    Oh, Sung Yong
    Pak, Min-Kyoung
    Kim, Ki-Ho
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2020, 13 (07): : 1682 - 1687